Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Mitsubishi Chemical Taps Belgium-Born Gilson as Its First Foreign CEO
October 26, 2020
- Exploratory Trial of Neuro-Protective/Regenerative Sheets to Be Launched for CTS: Osaka Univ., NIMS, Nippon Zoki
October 26, 2020
- Nichi-Iko’s Remicade Biosimilar Adds Ankylosing Spondylitis Use
October 26, 2020
- Sanwa Kagaku’s SHPT Drug Meets Primary Goal in Japan PIII
October 26, 2020
- Cyberattacks Leak Data from Shionogi’s Taiwan Subsidiary
October 26, 2020
- Novartis Looks to Solidify Presence in Multiple Sclerosis Arena with Mayzent, then Ofatumumab
October 23, 2020
- Chugai Enjoys Higher Earnings in January-September on Hemlibra
October 23, 2020
- Fujifilm Taps Carelink as Chinese Partner for Avigan
October 23, 2020
- Daiichi Sankyo Kicks Off PI Study for I/O Therapy DS-1055
October 23, 2020
- AstraZeneca’s Japan COVID-19 Vaccine Trial Ongoing after Death Reported in Brazil
October 23, 2020
- Kyowa Kirin Delivers Positive PIIb Data for Parkinson’s Med KW-6356
October 22, 2020
- Aducanumab Filed in Europe: Biogen/Eisai
October 22, 2020
- Chugai Licenses Antibody Engineering Tech to Novo
October 22, 2020
- GSK Sets Up Oncology Biz Unit in Japan; Multiple Late-Stage Assets in Pipeline
October 22, 2020
- Pfizer, BioNTech Begin Japan PI/II Study for COVID-19 Vaccine
October 21, 2020
- Drug Promotions Collectively Down in August: Intage
October 21, 2020
- Astellas Wins FDA’s Fast-Track Tag for Primary Mitochondrial Myopathies Drug
October 21, 2020
- Sawai to Launch Zagallo Generic on Nov. 6
October 20, 2020
- Pfizer Starts Promotion for 4 Authorized Generics, Including Lyrica AG
October 20, 2020
- LEO Pharma’s Atopic Dermatitis Program Lags as PMDA Requests Japanese Data, but Growth Goal Intact
October 20, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…